Staidson BioPharm: Application for stock issuance to specific objects accepted by Shenzhen Stock Exchange
Staidson BioPharm announced that on October 24, 2025, it received a notice from the Shenzhen Stock Exchange that its application documents for issuing shares to specific objects have been accepted. This issuance still needs to be approved by the Shenzhen Stock Exchange and obtain the registration decision from the China Securities Regulatory Commission before it can be implemented. There is uncertainty regarding whether it will pass the review and the timeline, and the company will disclose progress in a timely manner
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments